Overview
Craig Gordon is a Hematologist Oncology specialist and a Hematologist in Farmington Hills, Michigan. Dr. Gordon is rated as an Experienced provider by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. His top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Paget Disease of the Breast, Bone Marrow Aspiration, and Gastrostomy. Dr. Gordon is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
University Physician Group
Joseph Uberti is a Hematologist Oncology specialist and an Oncologist in Detroit, Michigan. Dr. Uberti is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. His top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Uberti is currently accepting new patients.
Regents Of The University Of Michigan
Dale Bixby is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Bixby is rated as an Elite provider by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is currently accepting new patients.
Regents Of The University Of Michigan
Patrick Burke is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Burke is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloblastic Leukemia with Maturation. His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Aplastic Anemia, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration. Dr. Burke is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Gordon isAdvanced. Learn about Anemia.
- Breast CancerDr. Gordon isAdvanced. Learn about Breast Cancer.
- Childhood Acute Myeloid LeukemiaDr. Gordon isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Colorectal CancerDr. Gordon isAdvanced. Learn about Colorectal Cancer.
- Congenital Anti-Plasmin Deficiency
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Gordon isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adrenal CancerDr. Gordon isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Gordon isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Immune ThrombocytopeniaDr. Gordon isExperienced. Learn about Adult Immune Thrombocytopenia.